New User? Click here to register

Updated HR+/HER2- metastatic management.

Text generated by AI based on an exclusive interview, revised and reviewed by

Dr Jean-Philippe MINART, Cannes, France

October 20, 2023

Hassan GHAZAL, MD, Dubai UAE, Medical Oncologist and Hematologist, Dubai, UAE

Hassan GHAZAL
MD, Dubai UAE, Medical Oncologist and Hematologist, Dubai, UAE

Comment améliorer les stratégies thérapeutiques en radiothérapie des carcinomes in situ dans les sous groupes à bas risque ?
Yazid BELKACEMI

Radiotherapeute, Paris, France
What are the limitation of mammography?
Dana HADDAD
radiologist, UAE
Does the primary tumor localization have an impact on liver metastatic surgery?
Rakesh Rai
Radiotherapy: Indications and progress in IDC.
Yazid BELKACEMI
New drugs and options: Are there drugs that must be offered to patients in 2022?
Joseph GLIGOROV